FOXM1和CHD4的表达与肝细胞瘤中的化学抵抗有关
Yuko Hino1, Kenichi Kohashi2, Akihiko Tamaki3
1Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Pediatric Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Pathology, research and practice
|May 18, 2024
概括
叉头盒蛋白M1 (FOXM1) 可能预测肝细胞母细胞瘤 (HB) 的治疗反应. 高FOXM1表达与基斯基化疗的较差结果相关,这表明其在评估儿童肝癌治疗有效性的有用性.
科学领域:
- 在瘤学瘤学.
- 儿科病理学 儿科病理学
- 分子生物学分子生物学
背景情况:
- 肝细胞瘤 (HB) 是最常见的儿科肝脏恶性瘤.
- 基于西斯普拉丁 (CDDP) 的化疗是标准的,但CDDP耐药性发生在约20%的HB病例中.
- 叉头盒蛋白M1 (FOXM1) 和染色域-酶-DNA结合蛋白4 (CHD4) 都与CDDP耐药性有关.
研究的目的:
- 在化学治疗后的儿科肝细胞母细胞瘤样本中研究FOXM1和CHD4的免疫组织化学表达.
- 为了将FOXM1和CHD4表达与瘤分化和化疗反应相关联.
- 评估FOXM1作为一种生物标志物在HB中CDDP治疗疗效的实用性.
主要方法:
- 在33名HB患者样本中对FOXM1和CHD4进行免疫组织化学分析.化疗后.
- 数字病理学软件 (QuPath®) 用于样本差异化评估.
- 蛋白质表达,临床病理学参数和化疗反应标记 (AFP,成像收缩,组织学残留率) 之间的相关性分析.
主要成果:
- 无论FOXM1和CHD4的免疫表达在胚胎的比胎儿的HB组件显著更高.
- 高的FOXM1分数与术后较高的α-fetoprotein (AFP) 水平和较低的AFP衰减率相关.
- FOXM1表达与成像收缩或组织学残留率无关;CHD4显示非显著的趋势.
结论:
- 在肝细胞瘤中,FOXM1表达可以作为评估对基于CDDP的化疗反应的有价值指标.
- 准确的FOXM1量化,可能使用数字病理学,对于混合HB组件病例很重要.
- 对FOXM1的作用的进一步研究可以完善儿科肝癌的治疗策略.
相关概念视频
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K


